MEDP MEDPACE HLDGS INC revenue, earnings and financials

For the quarter ended September 30, 2026, MEDPACE HLDGS INC reported revenue of $716M (up 8.5% from a year earlier), net income of $137M and diluted EPS of $4.84; over the last four quarters revenue was $2.84B and net income $518M; for the fiscal year ended December 2025 revenue was $2.53B, up 20.0% on the year before.

MEDP annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $2.53B, gross profit n/a, operating income $535M, net income $451M (margin 17.8%), EPS $15.28
• Fiscal year ended Dec 2024: revenue $2.11B, gross profit n/a, operating income $447M, net income $404M (margin 19.2%), EPS $12.63
• Fiscal year ended Dec 2023: revenue $1.89B, gross profit n/a, operating income $337M, net income $283M (margin 15.0%), EPS $8.88
• Fiscal year ended Dec 2022: revenue $1.46B, gross profit n/a, operating income $279M, net income $245M (margin 16.8%), EPS $7.28
• Fiscal year ended Dec 2021: revenue $1.14B, gross profit n/a, operating income $199M, net income $182M (margin 15.9%), EPS $4.81

MEDP quarterly revenue and earnings

• Quarter ended Sep 30, 2026: revenue $716M (up 8.5% year over year), net income $137M, EPS $4.84
• Quarter ended Jun 30, 2026: revenue $707M (up 17.2% year over year), net income $121M, EPS $4.25
• Quarter ended Mar 31, 2026: revenue $707M (up 26.5% year over year), net income $124M, EPS $4.28
• Quarter ended Dec 31, 2025 (from the annual report): revenue $708M (up 32.0% year over year), net income $135M, EPS $4.65
• Quarter ended Sep 30, 2025: revenue $660M (up 23.7% year over year), net income $111M, EPS $3.86
• Quarter ended Jun 30, 2025: revenue $603M (up 14.2% year over year), net income $90.3M, EPS $3.10
• Quarter ended Mar 31, 2025: revenue $559M (up 9.3% year over year), net income $115M, EPS $3.67
• Quarter ended Dec 31, 2024 (from the annual report): revenue $537M (up 7.7% year over year), net income $117M, EPS $3.67
• Quarter ended Sep 30, 2024: revenue $533M (up 8.3% year over year), net income $96.4M, EPS $3.01
• Quarter ended Jun 30, 2024: revenue $528M (up 14.6% year over year), net income $88.4M, EPS $2.75
• Quarter ended Mar 31, 2024: revenue $511M (up 17.7% year over year), net income $103M, EPS $3.20
• Quarter ended Dec 31, 2023 (from the annual report): revenue $498M (up 26.5% year over year), net income $78.3M, EPS $2.46
• Quarter ended Sep 30, 2023: revenue $492M (up 28.3% year over year), net income $70.6M, EPS $2.22
• Quarter ended Jun 30, 2023: revenue $461M (up 31.2% year over year), net income $61.1M, EPS $1.93
• Quarter ended Mar 31, 2023: revenue $434M (up 31.2% year over year), net income $72.9M, EPS $2.27
• Quarter ended Dec 31, 2022 (from the annual report): revenue $394M (up 27.7% year over year), net income $68.7M, EPS $2.08
• Quarter ended Sep 30, 2022: revenue $384M (up 29.8% year over year), net income $66.0M, EPS $2.05
• Quarter ended Jun 30, 2022: revenue $351M (up 26.2% year over year), net income $49.4M, EPS $1.46
• Quarter ended Mar 31, 2022: revenue $331M (up 27.3% year over year), net income $61.3M, EPS $1.69
• Quarter ended Dec 31, 2021 (from the annual report): revenue $309M, net income $50.0M, EPS $1.32

MEDP cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $713M, share buybacks $917M
• Fiscal year ended Dec 2024: operating cash flow $609M, share buybacks $170M
• Fiscal year ended Dec 2023: operating cash flow $433M, share buybacks $144M
• Fiscal year ended Dec 2022: operating cash flow $388M, share buybacks $848M
• Fiscal year ended Dec 2021: operating cash flow $263M, share buybacks $62.1M

MEDP balance sheet

• Sep 30, 2026: cash $705M, total assets $2.30B, total liabilities $1.72B, shareholders' equity $585M
• Jun 30, 2026: cash $503M, total assets $2.06B, total liabilities $1.62B, shareholders' equity $434M
• Mar 31, 2026: cash $653M, total assets $2.13B, total liabilities $1.53B, shareholders' equity $598M
• Dec 31, 2025: cash $497M, total assets $1.98B, total liabilities $1.52B, shareholders' equity $459M
• Sep 30, 2025: cash $285M, total assets $1.75B, total liabilities $1.46B, shareholders' equity $294M
• Jun 30, 2025: cash $46.3M, total assets $1.57B, total liabilities $1.40B, shareholders' equity $172M
• Mar 31, 2025: cash $441M, total assets $1.90B, total liabilities $1.30B, shareholders' equity $594M
• Dec 31, 2024: cash $669M, total assets $2.10B, total liabilities $1.28B, shareholders' equity $826M

What is MEDP's revenue?

MEDPACE HLDGS INC reported $2.84B of revenue over its last four quarters, through September 30, 2026.

Is MEDP profitable?

Yes. MEDPACE HLDGS INC earned $518M over the last four quarters.

What is MEDP's EPS?

Diluted earnings per share over the last four quarters were $18.02; $4.84 in the latest quarter.

MEDP ownership and insider trades · All stocks